Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclusive licensing agreement for commercializing Ryaltris Nasal Spray in Singapore, Hong Kong and Vietnam

Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd

Related Keywords

Malaysia ,Australia ,Taiwan ,Japan ,Philippines ,United States ,Hong Kong ,United Kingdom ,Uzbekistan ,China ,Vietnam ,Republic Of ,Czech Republic ,Yuhan ,Anhui ,South Africa ,Canada ,Russia ,Ukraine ,Thailand ,Mumbai ,Maharashtra ,India ,Singapore ,South Korea ,Poland ,Switzerland ,Swiss ,Robert Crockart ,Petar Vazharov ,Udaykumar Murthy ,Seqirus Pty ,Yuhan Corporation ,Lotus ,Lotus Pharmaceutical Co Ltd ,Corporate Communications ,Lotus International Pte ,Glenmark Pharmaceuticals Limited ,Health Canada ,Company Rankings ,Glenmark Pharmaceuticals Ltd ,Bausch Health ,Glenmark Pharmaceuticals ,Lotus International ,South East Asian ,Chief Commercial Officer ,Chief Executive Officer ,South East ,Allergic Inflammation ,Nasal Mucosa ,Hikma Specialty United ,Grand Pharma ,Pharmaceuticals Limited ,Generics Bulletin ,Dow Jones Sustainability Index ,Corporate Sustainability ,Deputy General Manager ,Glenmark ,Specialty ,A ,End ,Nternational ,Vote ,Td ,Winter ,Into ,Exclusive ,Icensing ,Agreement ,Or ,Commercializing ,Ryaltris ,Nasal ,Spray ,N , ,Song ,News ,Ews India ,